Navigation Links
CeloNova BioSciences Announces Positive Results from European Study of Embozene(TM) Microspheres for Treatment of Uterine Fibroids
Date:1/19/2008

ATLANTA, Jan. 20 /PRNewswire/ -- CeloNova BioSciences, Inc. ("CeloNova"), leading and accelerating healthcare solutions through the provision and development of innovative medical devices, has released data from THE SPHERE, an 11 center, 8 country European study of uterine fibroid embolization using the Company's Embozene(TM) Microspheres. The study results were reported at the 20th Annual International Symposium on Endovascular Therapy.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080120/CLSU001 )

Patients in the study were followed for six months. According to one of the Principal Investigators, Joachim Kettenbach, MD, Medical University of Vienna, "Technical success was achieved in 98% of the patients. The side- effects of fibroids such as pain and heavy menstrual bleeding were significantly reduced while the patients' quality of life improved substantially."

Embolization is a minimally invasive procedure for uterine fibroids during which an Interventional Radiologist injects microspheres through a tiny catheter to the site of the fibroid. The microspheres -- each about the size of a period at the end of this sentence -- block the blood flow to the fibroids causing them to atrophy. The procedure is an alternative for most women with fibroids to surgical procedures such as hysterectomy or myomectomy. Recovery time is measured in days rather than weeks.

CeloNova's Embozene(TM) Color-Advanced Microspheres are the only microspheres that are color-coded by size. They have a hydrogel center and an outer layer of the Company's proprietary coating, Polyzene(R)-F which enhances biocompatibility.

"From the beginning, CeloNova has operated on the principle that our products would give first-rate clinical outcomes for patients and meet the real-world needs of physicians," said Thomas A. Gordy, President and Chief Executive Officer. Gordy continued, "Thi
'/>"/>

SOURCE CeloNova BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
2. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
3. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
4. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
5. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
6. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
7. Alacrity Biosciences Announces Positive Results from a Phase 2 Study of Its Dry Eye Treatment ALTY-0501
8. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
9. Regado Biosciences Initiates Phase IIa Clinical Study of REG1 Anticoagulation System
10. Regado Biosciences Presents Positive Data From REG1 Anticoagulation System Phase Ic Study at American Heart Association 2007 Scientific Sessions
11. Regado Biosciences Presents Early Stage Clinical Data for REG1 Anticoagulation System at American Heart Association 2007 Scientific Sessions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... , July 2, 2015  The Green Exchange, ... the world,s first HIPAA compliant mobile app that connects ... farm-to-table fresh medical marijuana, announced today that their service ... Unlike Eaze, Meadow and more than half a dozen ... last year, Loud Cannabis is unique in that it ...
(Date:7/2/2015)... The report "Silage Inoculants & ... Pediococcus & Enterococcus), Enzymes (Fibre-digesting & Starch-digesting), Crop-type & ... Inoculants & Enzymes Market is expected to reach $489.05 ... 2015 to 2020. Browse 75 market ... P ages and an in-depth TOC ...
(Date:7/2/2015)... 2, 2015  The Commission for Certification in ... an organization that represents pharmacists in acute and ... continuing education for recertification of Certified Geriatric Pharmacists.  ... programs for this purpose.  ASHP will join the ... for the CCGP Professional Development Program. ...
Breaking Medicine Technology:New Cannabis Delivery App Gets Product to Patient in Under 7 Minutes 2Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 2Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 3Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 4Commission for Certification in Geriatric Pharmacy Adds ASHP as Professional Development Program Provider 2
... Incorporated,(Nasdaq: VPHM ) today announced that Michel de ... at the Acumen BioFin Rodman &,Renshaw 9th Annual Healthcare ... The conference is being held at the New York ... investors through, http://www.viropharma.com and available through November 20, ...
... Research,Associates, LLC announced today that it has ... Corporation (Amex: CVM ). The,full 56-page ... . CEL-SCI Corporation develops immune-based cancer ... is Multikine(R), a,next-generation, comprehensive immunotherapy that targets ...
Cached Medicine Technology:Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation 2Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation 3
(Date:7/3/2015)... ... 2015 , ... B. E. Smith, the only full-service leadership ... national chief nursing officer recruitment for Jane Phillips Medical Center in ... B. E. Smith has recently placed more than 1,000 healthcare executives into organizations. ...
(Date:7/3/2015)... ... July 03, 2015 , ... Talcum powder attorneys representing clients in national ... Powder Cancer Lawsuit Center website. Just as the previous version did, the new website ... timely lawsuit updates and ovarian cancer warning information. The site is routinely updated with ...
(Date:7/3/2015)... ... ... Selfie on a Stick ” was featured on NewsWatch as part of its monthly ... Forstrom, a technology expert and special reporter for NewsWatch, conducted the review and shared ... smartphone has an incredibly powerful camera built into it. And when someone is traveling ...
(Date:7/3/2015)... ... July 03, 2015 , ... The Celebrity Dresses is currently ... similar to those of celebrities will have the opportunity to get 10% discount on ... ensures that people do not have to use coupon codes or remember redemption codes. ...
(Date:7/2/2015)... (PRWEB) , ... July 02, 2015 , ... sweetFrog Enterprises, ... The opening is now the 19th sweetFrog store located in the Lone Star State. ... of fastest growing companies in 2014. , The store, which opened July 1 at ...
Breaking Medicine News(10 mins):Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 3Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 2Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 3Health News:Learn How to Take Selfies like Kendall Jenner 2Health News:Celebrity Fashion Summer Party Dresses on sale at TheCelebrityDresses.com 2Health News:sweetFrog Expands Texas Footprint with Location in Canton 2
... a protein frequently found in melanoma tumors, doctors may ... chemotherapy, according to early results of a clinical study ... , "In this pilot study, we gave patients with ... in pre-clinical studies to weaken melanoma tumors by targeting ...
... Mass., March 6 Palomar Medical Technologies, Inc. (Nasdaq: ... of light-based systems for cosmetic treatments, announced today that ... Optic(TM), the GROOVE Optic(TM), LuxPowR(TM) pulsed-light handpiece and a ... 67th Annual Meeting of the American Academy of Dermatology ...
... Ltd. will be unveiling a new diagnostic ultrasound system ... to be held from March 6th, 2009 in Vienna, ... with higher cost-effectiveness, flexibility, ease of use, and functionality. ... with the latest digital technologies engineered into a compact ...
... release is available in German . , ... in the treatment of certain brain tumours. This has been ... German and Swiss colleagues in a current study. They treated ... The patients survived on average 23 months; with the standard ...
... and allied professional are already at the heart of ... Professor Christi Deaton, Chairperson of the ESC Council on ... greater role given the complex needs of people with ... cardiovascular disease," says Professor Deaton, "and we have seen ...
... and removal of precancerous polyps among key factors in ... March 6 /PRNewswire-USNewswire/ -- Colorectal cancer, also ... most preventable cancers. Recent statistics show that the incidence ... death rates from colorectal cancer are declining, in part ...
Cached Medicine News:Health News:Drug combination may be effective against deadly melanoma, pilot study shows 2Health News:Palomar Medical to Debut New Devices and a More Powerful Platform at the American Academy of Dermatology Annual Meeting 2Health News:Palomar Medical to Debut New Devices and a More Powerful Platform at the American Academy of Dermatology Annual Meeting 3Health News:Palomar Medical to Debut New Devices and a More Powerful Platform at the American Academy of Dermatology Annual Meeting 4Health News:Palomar Medical to Debut New Devices and a More Powerful Platform at the American Academy of Dermatology Annual Meeting 5Health News:Palomar Medical to Debut New Devices and a More Powerful Platform at the American Academy of Dermatology Annual Meeting 6Health News:ALOKA Showcases a New Diagnostic Ultrasound System ProSound 4 at ECR 2009 in Vienna, Austria 2Health News:Brain tumors: New therapy surprisingly successful 2Health News:Nurses and allied professionals at heart of cardiovascular prevention and management programs 2Health News:Nurses and allied professionals at heart of cardiovascular prevention and management programs 3Health News:March is National Colorectal Cancer Awareness Month: Do You Know What Your Screening Options Are? 2Health News:March is National Colorectal Cancer Awareness Month: Do You Know What Your Screening Options Are? 3Health News:March is National Colorectal Cancer Awareness Month: Do You Know What Your Screening Options Are? 4Health News:March is National Colorectal Cancer Awareness Month: Do You Know What Your Screening Options Are? 5Health News:March is National Colorectal Cancer Awareness Month: Do You Know What Your Screening Options Are? 6Health News:March is National Colorectal Cancer Awareness Month: Do You Know What Your Screening Options Are? 7
... three-level control for monitoring and ... confirm cystic fibrosis. The controls ... Chloridometer, Flame Photometer, Osmometer, Sweat-Chek ... & Schales Titration, Synchron and ...
... designed to validate HDL cholesterol plus other ... This control is compatible with most major ... Synchron and Vitros. HDL values are given ... methods: Dextran Sulfate 50,000 MW. Apolipoprotein A-1 ...
... is intended as a means ... ethanol assay methods. This ready-to-use, ... clinically significant levels of ammonia ... provided for the following instruments: ...
... is intended as a means ... assay methods used for the ... urine samples. This control is ... This control is supplied as ...
Medicine Products: